|
Video: What is a Stock Split?
|
|
AVEO Pharmaceuticals is a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines for patients with cancer. Co.'s product candidates include: Tivozanib, which is for the treatment of renal cell carcinoma, hepatocellular carcinoma, immunologically cold tumors and cholangiocarcinoma; Ficlatuzumab, which is a humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets hepatocyte growth factor; AV-380, which is a humanized IgG1 monoclonal antibody that targets growth differentiation factor 15; AV-203, which is a humanized IgG1 monoclonal antibody that targets ErbB3; and AV-353, which is a IgG1 monoclonal antibody that targets the Notch 3 pathway. According to our AVEO stock split history records, AVEO has had 1 split. | |
|
AVEO (AVEO) has 1 split in our AVEO stock split history database. The split for AVEO took place on February 20, 2020. This was a 1 for 10 reverse split, meaning for each 10 shares of AVEO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split.
When a company such as AVEO conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the AVEO stock split history from start to finish, an original position size of 1000 shares would have turned into 100 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into AVEO shares, starting with a $10,000 purchase of AVEO, presented on a split-history-adjusted basis factoring in the complete AVEO stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/25/2014 |
|
End date: |
01/19/2023 |
|
Start price/share: |
$13.00 |
|
End price/share: |
$15.00 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
15.38% |
|
Average Annual Total Return: |
1.65% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$11,538.15 |
|
Years: |
8.74 |
|
|
|
Date |
Ratio |
02/20/2020 | 1 for 10 |
|
|